This inventor holds 5 USPTO granted patents and 18 published patent applications. Top assignee: Emendobio Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Liat Rockah: Innovator in Genetic Research
Introduction
Liat Rockah is a prominent inventor based in Rishon LeZion, Israel. He has made significant contributions to the field of genetic research, particularly in the development of methods to address genetic mutations. With a total of four patents to his name, Rockah is recognized for his innovative approaches to complex genetic challenges.
Latest Patents
Among his latest patents is a method to inactivate a mutant allele of the elastase, neutrophil expressed gene (ELANE gene). This method specifically targets mutations associated with severe congenital neutropenia (SCN) or cyclic neutropenia (CyN). Another notable patent is the OMNI-103 CRISPR nuclease, which provides a non-naturally occurring composition comprising a CRISPR nuclease with a sequence having at least 95% identity to a specific amino acid sequence. These inventions showcase Rockah's commitment to advancing genetic therapies.
Career Highlights
Liat Rockah has established himself as a key figure in genetic innovation. His work has not only contributed to scientific knowledge but also holds the potential for practical applications in treating genetic disorders. His expertise in CRISPR technology positions him at the forefront of genetic research.
Collaborations
Rockah collaborates with notable colleagues, including Lior Izhar and Nurit Meron. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.
Conclusion
Liat Rockah's contributions to genetic research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in genetic therapies and treatments.